These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8305878)

  • 21. Recovery from alloxan diabetes as revealed by collagen characteristics of bone, skin and tendon of Swiss mice.
    Behera HN; Patnaik BK
    Gerontology; 1981; 27(1-2):32-6. PubMed ID: 7215817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus.
    Hampson G; Evans C; Petitt RJ; Evans WD; Woodhead SJ; Peters JR; Ralston SH
    Diabetologia; 1998 Nov; 41(11):1314-20. PubMed ID: 9833939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat.
    Creecy A; Uppuganti S; Merkel AR; O'Neal D; Makowski AJ; Granke M; Voziyan P; Nyman JS
    Calcif Tissue Int; 2016 Sep; 99(3):289-301. PubMed ID: 27209312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
    Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
    J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased collagen production in diabetic rats.
    Spanheimer RG; Umpierrez GE; Stumpf V
    Diabetes; 1988 Apr; 37(4):371-6. PubMed ID: 3378683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and development of the bone mass of two strains of inbred rats.
    Puche RC; Alloatti R; Ledesma S
    Bone Miner; 1988 Sep; 4(4):341-53. PubMed ID: 3191289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats.
    Verhaeghe J; Thomsen JS; van Bree R; van Herck E; Bouillon R; Mosekilde L
    Bone; 2000 Aug; 27(2):249-56. PubMed ID: 10913918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
    Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
    Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral trypsin-inhibitor-induced improvement of the exocrine and endocrine pancreatic functions in alloxan diabetic rats.
    Ihse I; Lundquist I; Arnesjö B
    Scand J Gastroenterol; 1976; 11(4):363-8. PubMed ID: 779003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats.
    Bain S; Ramamurthy NS; Impeduglia T; Scolman S; Golub LM; Rubin C
    Bone; 1997 Aug; 21(2):147-53. PubMed ID: 9267690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization.
    Goodman WG; Hori MT
    Diabetes; 1984 Sep; 33(9):825-31. PubMed ID: 6381178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound collagenase activity correlates directly with collagen glycosylation in diabetic rats.
    Hennessey PJ; Ford EG; Black CT; Andrassy RJ
    J Pediatr Surg; 1990 Jan; 25(1):75-8. PubMed ID: 2153794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus.
    Hamann C; Picke AK; Campbell GM; Balyura M; Rauner M; Bernhardt R; Huber G; Morlock MM; Günther KP; Bornstein SR; Glüer CC; Ludwig B; Hofbauer LC
    Endocrinology; 2014 Apr; 155(4):1197-206. PubMed ID: 24467747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral density and composition in rat pregnancy: effects of streptozotocin-induced diabetes mellitus and insulin replacement.
    Tein MS; Breen SA; Loveday BE; Devlin H; Balment RJ; Boyd RD; Sibley CP; Garland HO
    Exp Physiol; 1998 Mar; 83(2):165-74. PubMed ID: 9568476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone calcification and calcium homeostasis in rats with non-insulin-dependent diabetes induced by streptozocin.
    Levy J; Teitelbaum SL; Gavin JR; Fausto A; Kurose H; Avioli LV
    Diabetes; 1985 Apr; 34(4):365-72. PubMed ID: 3972185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose utilization and anti-oxidative mechanisms of the aqueous hunteria umbellata seed extract in alloxan-induced diabetic rats.
    Adeneye AA; Adenekan SO; Adeyemi OO; Agbaje EO
    Niger J Physiol Sci; 2014 Jun; 29(1):71-9. PubMed ID: 26196570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological responses to acute stress in alloxan and streptozotocin diabetic rats.
    Lee JH; Konarska M; McCarty R
    Physiol Behav; 1989 Mar; 45(3):483-9. PubMed ID: 2526954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptozotocin and alloxan are comparable agents in the diabetic model of impaired wound healing.
    Covington DS; Xue H; Pizzini R; Lally KP; Andrassy RJ
    Diabetes Res; 1993; 23(2):47-53. PubMed ID: 7712679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of streptozotocin and alloxan induced diabetes on the metabolism of dermal collagen in albino rats.
    Mohanam S; Bose S
    Acta Diabetol Lat; 1981; 18(3):251-8. PubMed ID: 6458190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats.
    Glorie L; Behets GJ; Baerts L; De Meester I; D'Haese PC; Verhulst A
    Am J Physiol Endocrinol Metab; 2014 Sep; 307(5):E447-55. PubMed ID: 25053403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.